Coronavirus Update: U.S. COVID vaccine program faces setback with J&J jab, as experts say there is no cause for alarm


The U.S. COVID-19 vaccine program was facing a setback Tuesday, when the nation’s two leading health agencies recommended a pause in the use of the Johnson & Johnson vaccine to allow their scientists investigate six cases of blood clotting in individuals who had been vaccinated.

Need to Know: Here’s where investors see a market bubble — and it isn’t stocks, says Bank of America

Previous article

Bond Report: 10-year Treasury yield slips to around three-week low despite U.S. March inflation surge

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News